Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × SCLC × Drug Therapy × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 31 Neoplasms 25 Colorectal Neoplasms 18 Ovarian Neoplasms 14 Breast Neoplasms 14 Neoplasm Metastasis 12 Pancreatic Neoplasms 10 Lung Neoplasms 10 Stomach Neoplasms 9 Melanoma 8 Leukemia, Myeloid, Acute 8 Lymphoma, Non-Hodgkin 7 Small Cell Lung Carcinoma 6 Recurrence 6 Liver Neoplasms 5 Leukemia 5 Head and Neck Neoplasms 5 Fallopian Tube Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Lymphoma 4 Gastrointestinal Neoplasms 4 Cholangiocarcinoma 4 Adenocarcinoma 4 Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Precision Cell Immunotherapy 3 Neoplasms by Site 3

Interventions

Paclitaxel 2 Etoposide 2 Carboplatin 2 sintilimab 1 atezolizumab 1 Topotecan 1 Platinum 1 Drug Therapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07145333 2025-09-08

Drug-SNP

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡